Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: Comparisons of phospholipid specificity, avidity and reactivity with β2-GPI

Journal of Autoimmunity

Volumn 13, Issue 3, 1999, Pages 347-355

  Petrovas, C ^a   Vlachoyiannopoulos, P G ^a   Kordossis, T ^a   Moutsopoulos, H M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Anti phospholipid antibodies; HIV infection; SLE; 2 glycoprotein I

Indexed keywords

CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BINDING AFFINITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032704761     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0324     Document Type: Article

References (44)

1. McNeil H.P., Chesterman C.N., Krilis S.A. Immunology and clinical importance of antiphospholipid antibodies. Adv. Immunol. 49:1991;193-280.
2. Sohngen D., Wehmeir A.A., Speeker C., Scheider W. Antiphospholipid antibodies in systemic lupus erythematosus and Sneddon's syndrome. Thromb. Haemost. 20:1994;55-63.
3. Hughes G.R.V., Harris E.N., Charavi A.E. The anticardiolipin syndrome. J. Rheumatol. 13:1986;486-489.
4. Charavi A.E., Samaritano L.R., Wen J., Miyawaki N., Morse J.H., Zarrabi M.H., Lockshin M.D. Characteristics of human-immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of β2 glycoprotein I on binding to phospholipid. J. Rheumatol. 21:1994;94-99.
5. McNeil H.P., Simpson R.J., Chesterman C.N., Krilis S.A. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β2 glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. U S A. 87:1990;4120-4124.
6. Galli M., Comfurius P., Maassen C., Henker H.C., DeBaets M.H., Van-Breda-Vriesman P.J.C., Barbui J., Zwaal R.F., Bevers E.M. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet. 335:1990;1544-1547.
7. Kandiah D.A., Krilis S.A. Immunology and methods of defection of antiphospholipid antibodies. Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y. The antiphospholipid syndrome. 1996;29-48 CRC Press, New York.
8. Bloom E.J., Abraus D.I., Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA. 256:1986;491-493.
9. Abuaf N., Laperche S., Rajoely B., Carsique R., Deschamps A., Rouquette A.M., Barthet C., Khaled Z., Marbot C., Saab N., Rosen J., Girard P.M., Rozenbaum W. Autoantibodies to phospholipids and to the coagulation protein in AIDS. Thromb. Haemost. 77:1997;856-861.
10. Canoso R.T., Zon L.I., Croopman J.E. Anticardiolipin antibodies associated with HTLV-infection. Br. J. Haematol. 65:1987;495-498.
11. Roubey R.A.S. Immunology of the antiphospholipid syndrome. Arthritis Rheum. 39:1996;1444-1454.
12. Guerin J., Feighery C., Sim R.B., Jackson J. Antibodies to β2-glycoprotein I-aspecific marker for the antiphospholipid syndrome. Clin. Exp. Immunol. 109:1997;304-309.
13. Weiss L., You J.F., Firal P., Gelas M.A., Senger D., Kazatchkine M.D. Anticardiolipin antibodies are associated with anti-endothelial cell antibodies but not with anti-β2-glycoprotein I, antibodies in HIV infection. Clin. Immunol. Immunopathol. 77:1995;69-74.
14. Hunt J.E., McNeil H.P., Morgan G.J. A phospholipid-β2 glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus. 1:1991;75-82.
15. 99 mTC- HMPACSPECT. Clin. Exp. Immunol. 94:1994;361-368.
16. Brew B.J., Miller J. Human immunodeficiency virus type 1-related transient neurological deficits. Am. J. Med. 101:1996;257-261.
17. Gris J.C., Toulon B., Brun S., Mangard C., Sarlat C., Schved J.F., Berln J. The relationship between plasma microparticles, proteins, and anticardiolipin antibodies in patients with human immunodeficiency virus infection. Thromb. Haemost. 76:1996;38-45.
18. Stimullar M.M., Quismorio F.P., McGehel N.G. Anticardiolipin antibodies in acquired immuno- deficiency syndrome. Arch. Intern. Med. 149:1989;1833-1835.
19. Panzer S., Stain C., Hubert H., Dudczak R., Lechner K. Anticardiolipin antibodies are elavated in HIV-L infected haemophiliacs but do not predict for disease progression. Thromb. Haemost. 61:1989;81-85.
20. Carreno L., Monteagudo I., Lopez-Congo F.J., Gonzales C., Perez T., Majou M.R., Samson J., Lapointe N. Anticardiolipin antibodies in pediatric patients with human immunodeficiency virus. J. Rheumatol. 21:1994;1344-1346.
21. Vlachoyiannopoulos P.G., Petrovas C., Tektonidou M., Krilis S.A., Moutsopoulos H.M. Antibodies to β2glycoprotein I: urea resistance, binding specificity and association with thrombosis. J. Clin. Immunol. 18:1998;380-391.
22. Morb. Mortal. Weekly Rep. 14:1993;1-18.
23. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShaul D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 15:1982;1271-1277.
24. Alarcon-Segovia D., Sanchez-Guerrero J. Primary antiphospholipid syndrome. J. Rheumatol. 16:1989;482-486.
25. Hasselaar P., Triplett D.A., Larue A., Derkesen R., Blokzizl L., de Groot P., Wagenknecht D., McIntyre I. Heat treatment of serum and plasma induces false positive results in the antiphospholipid antibody ELISA. J. Rheumatol. 17:1990;186-191.
26. Kouts S., Wang M.-X., Adelstein S., Krilis S.A. Immunization of a rabbit with β2glycoprotein I induces charge-dependent cross reactive antibodies that bind anionic phospholipid and have similar reactivity as autoimmune anti-phospholipids antibodies. J. Immunol. 155:1995;958-966.
27. Luk J., Kumar A., Tsang R., Staunton D. Biotinylated lipopolysaccharide binds to endotoxin receptor in endothelial and monocytic cells. Anal. Biochem. 232:1995;217-224.
28. Lane H.C., Masur H., Edgar L.C. Abnormalities of B-cell activation and immunoregulation in patients with acquired immunodeficiency syndrome. N. Engl. J. Med. 309:1983;453-458.
29. Amadori A., Zamarchi R., Ciminale V., DelMistro A., Siervo S., Alberti A., Colombatti M., Chieco-Bianchi L. HIV-1 specific B cell activation: a major constituent of spontaneous B-cell activation during HIV-infection. J. Immunol. 143:1989;2146-2152.
30. Bevers E.M., Confurius P., Zwaal R.F.A. Changes in membrane phospholipids distribution during platellet activation. Biochem. Biophys. Acta. 736:1983;57-66.
31. Mevorach D., Zhon J.L., Song X., Elkon K.B. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188:1998;387-392.
32. Meyaar L., Otto S.A., Jonker R., Mijuster M.I., Keet L.P.M., Miedema F. Programmed death of T-cells in HIV-1 infection. Science. 257:1992;217.
33. +T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:1992;331.
34. Stimuler M.M., Quismorio F.P., McGehee W.G. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch. Intern. Med. 149:1989;1833-1835.
35. Masala C., Sonce M., DiPrima M.A. Evidence for shared epitopes between cardiolipin and Pneumonocystis carinii. J. Infect. Dis. 160:1989;736-737.
36. Cacoub P., Musset L., Amoura Z., Guilani P., Chabre H., Lunel F., Poynard J., Opolon P., Piette J.G. Anticardiolipin, anti-β2glycoprotein I and anti-nucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. J. Rheumatol. 24:1997;2139-2144.
37. Thomas H.I.J., Wilson S., O'Toole C.M., Lister C.M., Saeed A.M., Watkins R.P.F., Morgan-Capner P. Differential maturation of avidity of IgG antibodies to gp41 (p24 and p17), following infection with HIV-1. Clin. Exp. Immunol. 103:1996;185-191.
38. Brostrom C., Sonnerborg A., Sallberg M. Human immunodeficiency virus type 1-infected patients with no disease progression display high avidity antibody production to autologous V3 sequences. J. Infect. Dis. 171:1995;509-511.
39. Kamoun P.P. Denaturation of globular proteins by urea: breakdown of hydrogen or hydrophobic bounds? Trends Biochem. Sci. 3:1988;424-425.
40. Pullen G.R., Fitzgerald G.M., Hosking C.S. Antibody avidity determination by ELISA using thiocynate elution. J. Immunol. Meth. 86:1986;83-87.
41. Dueymes M., Piette J.C., Le Tonquèze M., Bendaud B., Roué R., Garré M., Youinou P. Role of β2 glycoprotein I in anti-cardiolipin antibody affinity for phospholipid in autoimmune disease. Lupus. 4:1995;477-481.
42. Clements J.E., Montrelaro R.C., Zink M.C., Amedee A.M., Miller S., Trichel A.M., Jagerski B., Hauer D., Martin L.N., Bohm R.F. Cross protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69:1995;2737-2744.
43. Tzavara V., Vlachoyiannopoulos P.G., Kordossis T., Galaris D., Travlou A., Dafni U., Moutsopoulos H.M. Evidence for non-adaptive immune response in HIV infection. Eur. J. Clin. Invest. 27:1997;846-849.
44. Horkko S., Miller E., Dudl E., Raeven P., Curtiss L.K., Zvaifler N.J., Tackeltaub R., Pierangelli S.S., Branch D.W., Palinski W., Witztum J.L. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. J. Clin. Invest. 98:1996;815-825.